Free Trial

Lipocine (LPCN) Stock Chart & Stock Price History

Lipocine logo
$4.37 -0.08 (-1.80%)
As of 01/17/2025 04:00 PM Eastern

Lipocine Stock Price Performance

5 Day
Performance
-1.80%
1 Month
Performance
-10.27%
3 Month
Performance
-21.40%
6 Month
Performance
-22.65%
Year-To-Date
Performance
-10.45%
1 Year
Performance
+15.92%
Receive LPCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter.

LPCN Stock Chart for Tuesday, January, 21, 2025

Lipocine Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
01/20/2025$4.37$4.37$4.56$4.2542,027 shs$23.37 million
01/17/2025$4.45$4.37
-1.80%
$4.56$4.2542,027 shs$23.38 million
01/16/2025$4.62$4.45
-3.68%
$4.84$4.4213,454 shs$23.81 million
01/15/2025$4.60$4.62
+0.43%
$4.89$4.6231,200 shs$24.71 million
01/14/2025$4.59$4.60
+0.22%
$4.73$4.4814,404 shs$24.60 million
01/13/2025$4.89$4.59
-6.13%
$4.86$4.5048,867 shs$24.55 million
01/10/2025$5.23$4.89
-6.50%
$5.24$4.8230,976 shs$26.15 million
01/09/2025$5.23$5.23$5.40$4.9624,592 shs$27.97 million
01/08/2025$5.29$5.23
-1.13%
$5.40$4.9624,592 shs$27.97 million
01/07/2025$5.00$5.29
+5.80%
$5.50$5.0356,010 shs$28.29 million
01/06/2025$5.06$5.00
-1.19%
$5.20$5.009,784 shs$26.74 million
01/03/2025$4.86$5.06
+4.12%
$5.10$4.8224,777 shs$27.06 million
01/02/2025$4.88$4.86
-0.41%
$5.02$4.7630,166 shs$25.99 million
01/01/2025$4.88$4.88$5.06$4.5641,591 shs$26.10 million
12/31/2024$4.58$4.88
+6.55%
$5.06$4.5641,591 shs$26.10 million
12/30/2024$4.76$4.58
-3.78%
$4.79$4.5031,844 shs$24.49 million
12/27/2024$4.72$4.76
+0.85%
$4.91$4.5233,292 shs$25.46 million
12/26/2024$4.90$4.72
-3.67%
$5.22$4.6046,840 shs$25.25 million
12/25/2024$4.90$4.90$4.93$4.816,978 shs$26.22 million
12/24/2024$4.80$4.90
+2.08%
$4.93$4.816,978 shs$26.22 million
12/23/2024$4.87$4.80
-1.44%
$4.92$4.5765,186 shs$25.67 million
12/20/2024$4.68$4.87
+4.06%
$5.00$4.7064,292 shs$26.05 million


This page (NASDAQ:LPCN) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners